Epix Launches Appeal For FDA Approval Of Vasovist

Epix is seeking an advisory committee review of its Vasovist imaging agent, which will be marketed by Schering AG if approved.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet